Talk to us?

- NEETMDS- courses
NEET MDS Lessons
Periodontology

Necrotizing Ulcerative Gingivitis (NUG)

Necrotizing Ulcerative Gingivitis (NUG), also known as Vincent's disease or trench mouth, is a severe form of periodontal disease characterized by the sudden onset of symptoms and specific clinical features.

Etiology and Predisposing Factors

  • Sudden Onset: NUG is characterized by a rapid onset of symptoms, often following debilitating diseases or acute respiratory infections.
  • Lifestyle Factors: Changes in living habits, such as prolonged work without adequate rest, poor nutrition, tobacco use, and psychological stress, are frequently noted in patient histories .
  • Smoking: Smoking has been identified as a significant predisposing factor for NUG/NDP .
  • Immune Compromise: Conditions that compromise the immune system, such as poor oral hygiene, smoking, and emotional stress, are major contributors to the development of NUG .

Clinical Presentation

  • Symptoms: NUG presents with:
    • Punched-out, crater-like depressions at the crest of interdental papillae.
    • Marginal gingival involvement, with rare extension to attached gingiva and oral mucosa.
    • Grey, pseudomembranous slough covering the lesions.
    • Spontaneous bleeding upon slight stimulation of the gingiva.
    • Fetid odor and increased salivation.

Microbiology

  • Mixed Bacterial Infection: NUG is caused by a complex of anaerobic bacteria, often referred to as the fusospirochetal complex, which includes:
    • Treponema vincentii
    • Treponema denticola
    • Treponema macrodentium
    • Fusobacterium nucleatum
    • Prevotella intermedia
    • Porphyromonas gingivalis

Treatment

  1. Control of Acute Phase:

    • Clean the wound with an antibacterial agent.
    • Irrigate the lesion with warm water and 5% vol/vol hydrogen peroxide.
    • Prescribe oxygen-releasing mouthwash (e.g., hydrogen peroxide DPF, sodium perborate DPF) to be used thrice daily.
    • Administer oral metronidazole for 3 to 5 days. If sensitive to metronidazole, prescribe penicillin; if sensitive to both, consider erythromycin or clindamycin.
    • Use 2% chlorhexidine in select cases for a short duration.
  2. Management of Residual Condition:

    • Remove predisposing local factors (e.g., overhangs).
    • Perform supra- and subgingival scaling.
    • Consider gingivoplasty to correct any residual gingival deformities.

Microbes in Periodontics

Bacteria Associated with Periodontal Health

  • Primary Species:

    • Gram-Positive Facultative Bacteria:
      • Streptococcus:
        • S. sanguis
        • S. mitis
        • A. viscosus
        • A. naeslundii
      • Actinomyces:
        • Beneficial for maintaining periodontal health.
  • Protective or Beneficial Bacteria:

    • Key Species:
      • S. sanguis
      • Veillonella parvula
      • Corynebacterium ochracea
    • Characteristics:
      • Found in higher numbers at inactive periodontal sites (no attachment loss).
      • Low numbers at sites with active periodontal destruction.
      • Prevent colonization of pathogenic microorganisms (e.g., S. sanguis produces peroxide).
  • Clinical Relevance:

    • High levels of C. ochracea and S. sanguis are associated with greater attachment gain post-therapy.

Microbiology of Chronic Plaque-Induced Gingivitis

  • Composition:

    • Roughly equal proportions of:
      • Gram-Positive: 56%
      • Gram-Negative: 44%
      • Facultative: 59%
      • Anaerobic: 41%
  • Predominant Gram-Positive Species:

    • S. sanguis
    • S. mitis
    • S. intermedius
    • S. oralis
    • A. viscosus
    • A. naeslundii
    • Peptostreptococcus micros
  • Predominant Gram-Negative Species:

    • Fusobacterium nucleatum
    • Porphyromonas intermedia
    • Veillonella parvula
    • Haemophilus spp.
    • Capnocytophaga spp.
    • Campylobacter spp.
  • Pregnancy-Associated Gingivitis:

    • Increased levels of steroid hormones and P. intermedia.

Chronic Periodontitis

  • Key Microbial Species:

    • High levels of:
      • Porphyromonas gingivalis
      • Bacteroides forsythus
      • Porphyromonas intermedia
      • Campylobacter rectus
      • Eikenella corrodens
      • Fusobacterium nucleatum
      • Actinobacillus actinomycetemcomitans
      • Peptostreptococcus micros
      • Treponema spp.
      • Eubacterium spp.
  • Pathogenic Mechanisms:

    • P. gingivalis and A. actinomycetemcomitans can invade host tissue cells.
    • Viruses such as Epstein-Barr Virus-1 (EBV-1) and human cytomegalovirus (HCMV) may contribute to bone loss.

Localized Aggressive Periodontitis

  • Microbiota Characteristics:
    • Predominantly gram-negative, capnophilic, and anaerobic rods.
    • Almost all localized juvenile periodontitis (LJP) sites harbor A. actinomycetemcomitans, which can comprise up to 90% of the total cultivable microbiota.

Progression from Gingivitis to Periodontitis

The transition from gingivitis to periodontitis is a critical process in periodontal disease progression. This lecture will outline the key stages involved in this progression, highlighting the changes in microbial composition, host response, and tissue alterations.

Pathway of Progression

  1. Establishment and Maturation of Supragingival Plaque:

    • The process begins with the formation of supragingival plaque, which is evident in gingivitis.
    • As this plaque matures, it becomes more complex and can lead to changes in the surrounding tissues.
  2. Migration of Periodontopathogenic Bacteria:

    • When the microbial load overwhelms the local host immune response, pathogenic bacteria migrate subgingivally (below the gum line).
    • This migration establishes a subgingival niche that is conducive to the growth of periodontopathogenic bacteria.

Initial Lesion

  • Timeline:
    • The initial lesion, characterized by subclinical gingivitis, appears approximately 2 to 4 days after the colonization of the gingival sulcus by bacteria.
  • Clinical Manifestations:
    • Vasculitis: Inflammation of blood vessels in the gingival tissue.
    • Exudation of Serous Fluid: Increased flow of gingival crevicular fluid (GCF) from the gingival sulcus.
    • Increased PMN Migration: Polymorphonuclear neutrophils (PMNs) migrate into the sulcus in response to the inflammatory process.
    • Alteration of Junctional Epithelium: Changes occur at the base of the pocket, affecting the integrity of the junctional epithelium.
    • Collagen Dissolution: Perivascular collagen begins to dissolve, contributing to tissue breakdown.

Early Lesion

  • Timeline:
    • The early lesion forms within 4 to 7 days after the initial lesion due to the continued accumulation of bacterial plaque.
  • Characteristics:
    • Leukocyte Accumulation: There is a significant increase in leukocytes at the site of acute inflammation, indicating an ongoing immune response.
    • Cytopathic Alterations: Resident fibroblasts undergo cytopathic changes, affecting their function and viability.
    • Collagen Loss: Increased collagen loss occurs within the marginal gingiva, contributing to tissue destruction.
    • Proliferation of Basal Cells: The basal cells of the junctional epithelium proliferate in response to the inflammatory environment.

Periodontal Bone Grafts

Bone grafting is a critical procedure in periodontal surgery, aimed at restoring lost bone and supporting the regeneration of periodontal tissues.

1. Bone Blend

 Bone blend is a mixture of cortical or cancellous bone that is procured using a trephine or rongeurs, placed in an amalgam capsule, and triturated to achieve a slushy osseous mass. This technique allows for the creation of smaller particle sizes, which enhances resorption and replacement with host bone.

Particle Size: The ideal particle size for bone blend is approximately 210 x 105 micrometers.

Rationale: Smaller particle sizes improve the chances of resorption and integration with the host bone, making the graft more effective.

2. Types of Periodontal Bone Grafts

A. Autogenous Grafts

Autogenous grafts are harvested from the patient’s own body, providing the best compatibility and healing potential.

  1. Cortical Bone Chips

    • History: First used by Nabers and O'Leary in 1965.
    • Characteristics: Composed of shavings of cortical bone removed during osteoplasty and ostectomy from intraoral sites.
    • Challenges: Larger particle sizes can complicate placement and handling, and there is a potential for sequestration. This method has largely been replaced by autogenous osseous coagulum and bone blend.
  2. Osseous Coagulum and Bone Blend

    • Technique: Intraoral bone is obtained using high- or low-speed round burs and mixed with blood to form an osseous coagulum (Robinson, 1969).
    • Advantages: Overcomes disadvantages of cortical bone chips, such as inability to aspirate during collection and variability in quality and quantity of collected bone.
    • Applications: Used in various periodontal procedures to enhance healing and regeneration.
  3. Intraoral Cancellous Bone and Marrow

    • Sources: Healing bony wounds, extraction sockets, edentulous ridges, mandibular retromolar areas, and maxillary tuberosity.
    • Applications: Provides a rich source of osteogenic cells and growth factors for bone regeneration.
  4. Extraoral Cancellous Bone and Marrow

    • Sources: Obtained from the anterior or posterior iliac crest.
    • Advantages: Generally offers the greatest potential for new bone growth due to the abundance of cancellous bone and marrow.

B. Bone Allografts

Bone allografts are harvested from donors and can be classified into three main types:

  1. Undermineralized Freeze-Dried Bone Allograft (FDBA)

    • Introduction: Introduced in 1976 by Mellonig et al.
    • Process: Freeze drying removes approximately 95% of the water from bone, preserving morphology, solubility, and chemical integrity while reducing antigenicity.
    • Efficacy: FDBA combined with autogenous bone is more effective than FDBA alone, particularly in treating furcation involvements.
  2. Demineralized (Decalcified) FDBA

    • Mechanism: Demineralization enhances osteogenic potential by exposing bone morphogenetic proteins (BMPs) in the bone matrix.
    • Osteoinduction vs. Osteoconduction: Demineralized grafts induce new bone formation (osteoinduction), while undermineralized allografts facilitate bone growth by providing a scaffold (osteoconduction).
  3. Frozen Iliac Cancellous Bone and Marrow

    • Usage: Used sparingly due to variability in outcomes and potential complications.

Comparison of Allografts and Alloplasts

  • Clinical Outcomes: Both FDBA and DFDBA have been compared to porous particulate hydroxyapatite, showing little difference in post-treatment clinical parameters.
  • Histological Healing: Grafts of DFDBA typically heal with regeneration of the periodontium, while synthetic bone grafts (alloplasts) heal by repair, which may not restore the original periodontal architecture.

PERIOTEST Device in Periodontal Assessment

The PERIOTEST device is a valuable tool used in dentistry to assess the mobility of teeth and the reaction of the periodontium to applied forces. This lecture covers the principles of the PERIOTEST device, its measurement scale, and its clinical significance in evaluating periodontal health.

Function: The PERIOTEST device measures the reaction of the periodontium to a defined percussion force applied to the tooth. This is done using a tapping instrument that delivers a controlled force to the tooth.

Contact Time: The contact time between the tapping head and the tooth varies between 0.3 and 2 milliseconds. This duration is typically shorter for stable teeth compared to mobile teeth, allowing for a quick assessment of tooth stability.

PERIOTEST Scale

The PERIOTEST scale ranges from -8 to +50, with specific ranges indicating different levels of tooth mobility:

Readings Inference
-8 to 9 Clinically firm teeth
10 to 19 First distinguishable sign of movement
20 to 29 Crown deviates within 1 mm of its normal position
30 to 50 Mobility is readily observed

Clinical Significance

Assessment of Tooth Mobility:
The PERIOTEST device provides a quantitative measure of tooth mobility, which is essential for diagnosing periodontal disease and assessing the stability of teeth.

Correlation with Other Measurements:
The PERIOTEST values correlate well with:

  • Tooth Mobility Assessed with a Metric System: This allows for a standardized approach to measuring mobility, enhancing the reliability of assessments.

  • Degree of Periodontal Disease and Alveolar Bone Loss: Higher mobility readings often indicate more severe periodontal disease and greater loss of supporting bone, making the PERIOTEST a useful tool in monitoring disease progression.

Treatment Planning:
Understanding the mobility of teeth can aid in treatment planning, including decisions regarding periodontal therapy, splinting of mobile teeth, or extraction in cases of severe mobility.

Epithelial Turnover Rates in Oral Tissues

Epithelial turnover is a critical process in maintaining the health and integrity of oral tissues. Understanding the turnover rates of different epithelial types in the oral cavity can provide insights into their regenerative capabilities and responses to injury or disease.

Turnover Rates of Oral Epithelial Tissues

  1. Junctional Epithelium:

    • Turnover Rate1-6 days
    • Description:
      • The junctional epithelium is a specialized epithelial tissue that forms the attachment between the gingiva and the tooth surface.
      • Its rapid turnover rate is essential for maintaining a healthy seal around the tooth and for responding quickly to inflammatory changes or injury.
  2. Palate, Tongue, and Cheeks:

    • Turnover Rate5-6 days
    • Description:
      • The epithelial tissues of the hard palate, tongue, and buccal mucosa (cheeks) have a moderate turnover rate.
      • This relatively quick turnover helps maintain the integrity of these surfaces, which are subject to mechanical stress and potential injury from food and other environmental factors.
  3. Gingiva:

    • Turnover Rate10-12 days
    • Description:
      • The gingival epithelium has a slower turnover rate compared to the junctional epithelium and the epithelium of the palate, tongue, and cheeks.
      • This slower rate reflects the need for stability in the gingival tissue, which plays a crucial role in supporting the teeth and maintaining periodontal health.

Clinical Significance

  • Wound Healing:

    • The rapid turnover of the junctional epithelium is particularly important in the context of periodontal health, as it allows for quick healing of any disruptions caused by inflammation or mechanical trauma.
  • Response to Disease:

    • Understanding the turnover rates can help clinicians anticipate how quickly tissues may respond to treatment or how they may regenerate after surgical procedures.
  • Oral Health Maintenance:

    • The varying turnover rates highlight the importance of maintaining good oral hygiene practices to support the health of these tissues, especially in areas with slower turnover rates like the gingiva.

Effects of Smoking on the Etiology and Pathogenesis of Periodontal Disease

Smoking is a significant risk factor for the development and progression of periodontal disease. It affects various aspects of periodontal health, including microbiology, immunology, and physiology. Understanding these effects is crucial for dental professionals in managing patients with periodontal disease, particularly those who smoke.

Etiologic Factors and the Impact of Smoking

  1. Microbiology

    • Plaque Accumulation:
      • Smoking does not affect the rate of plaque accumulation on teeth. This means that smokers may have similar levels of plaque as non-smokers.
    • Colonization of Periodontal Pathogens:
      • Smoking increases the colonization of shallow periodontal pockets by periodontal pathogens. This can lead to an increased risk of periodontal disease.
      • There are higher levels of periodontal pathogens found in deep periodontal pockets among smokers, contributing to the severity of periodontal disease.
  2. Immunology

    • Neutrophil Function:
      • Smoking alters neutrophil chemotaxis (the movement of neutrophils towards infection), phagocytosis (the process by which neutrophils engulf and destroy pathogens), and the oxidative burst (the rapid release of reactive oxygen species to kill bacteria).
    • Cytokine Levels:
      • Increased levels of pro-inflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-α) and Prostaglandin E2 (PGE2) are found in the gingival crevicular fluid (GCF) of smokers. These cytokines play a role in inflammation and tissue destruction.
    • Collagenase and Elastase Production:
      • There is an increase in neutrophil collagenase and elastase in GCF, which can contribute to the breakdown of connective tissue and exacerbate periodontal tissue destruction.
    • Monocyte Response:
      • Smoking enhances the production of PGE2 by monocytes in response to lipopolysaccharides (LPS), further promoting inflammation and tissue damage.
  3. Physiology

    • Gingival Blood Vessels:
      • Smoking leads to a decrease in gingival blood vessels, which can impair the delivery of immune cells and nutrients to the periodontal tissues, exacerbating inflammation.
    • Gingival Crevicular Fluid (GCF) Flow:
      • There is a reduction in GCF flow and bleeding on probing, even in the presence of increased inflammation. This can mask the clinical signs of periodontal disease, making diagnosis more challenging.
    • Subgingival Temperature:
      • Smoking is associated with a decrease in subgingival temperature, which may affect the metabolic activity of periodontal pathogens.
    • Recovery from Local Anesthesia:
      • Smokers may require a longer time to recover from local anesthesia, which can complicate dental procedures and patient management.

Clinical Implications

  1. Increased Risk of Periodontal Disease:

    • Smokers are at a higher risk for developing periodontal disease due to the combined effects of altered microbial colonization, impaired immune response, and physiological changes in the gingival tissues.
  2. Challenges in Diagnosis:

    • The reduced bleeding on probing and altered GCF flow in smokers can lead to underdiagnosis or misdiagnosis of periodontal disease. Dental professionals must be vigilant in assessing periodontal health in smokers.
  3. Treatment Considerations:

    • Smoking cessation should be a key component of periodontal treatment plans. Educating patients about the effects of smoking on periodontal health can motivate them to quit.
    • Treatment may need to be more aggressive in smokers due to the increased severity of periodontal disease and the altered healing response.
  4. Monitoring and Maintenance:

    • Regular monitoring of periodontal health is essential for smokers, as they may experience more rapid disease progression. Tailored maintenance programs should be implemented to address their specific needs.

Explore by Exams